It was also reported that MYCN-amplified neuroblastoma cells rely on the amino acid transporter ASCT2 (solute carrier family 1 member 5, SLC1A5) for the provision of glutamine, in which its expression correlates with poor patient survival [49]. This evidence concerns the gene MYCN and neuroblastoma.